全文获取类型
收费全文 | 36320篇 |
免费 | 5508篇 |
国内免费 | 858篇 |
专业分类
耳鼻咽喉 | 63篇 |
儿科学 | 394篇 |
妇产科学 | 328篇 |
基础医学 | 3849篇 |
口腔科学 | 43篇 |
临床医学 | 3218篇 |
内科学 | 1045篇 |
皮肤病学 | 178篇 |
神经病学 | 80篇 |
特种医学 | 1678篇 |
外国民族医学 | 74篇 |
外科学 | 4848篇 |
综合类 | 4885篇 |
现状与发展 | 6篇 |
一般理论 | 1篇 |
预防医学 | 1553篇 |
眼科学 | 57篇 |
药学 | 2030篇 |
31篇 | |
中国医学 | 678篇 |
肿瘤学 | 17647篇 |
出版年
2024年 | 94篇 |
2023年 | 575篇 |
2022年 | 1039篇 |
2021年 | 1967篇 |
2020年 | 1831篇 |
2019年 | 1576篇 |
2018年 | 1505篇 |
2017年 | 1552篇 |
2016年 | 1676篇 |
2015年 | 2007篇 |
2014年 | 2494篇 |
2013年 | 2659篇 |
2012年 | 2067篇 |
2011年 | 2203篇 |
2010年 | 1661篇 |
2009年 | 1579篇 |
2008年 | 1602篇 |
2007年 | 1714篇 |
2006年 | 1733篇 |
2005年 | 1562篇 |
2004年 | 1289篇 |
2003年 | 1247篇 |
2002年 | 1032篇 |
2001年 | 910篇 |
2000年 | 729篇 |
1999年 | 633篇 |
1998年 | 506篇 |
1997年 | 487篇 |
1996年 | 401篇 |
1995年 | 335篇 |
1994年 | 250篇 |
1993年 | 228篇 |
1992年 | 190篇 |
1991年 | 183篇 |
1990年 | 130篇 |
1989年 | 117篇 |
1988年 | 115篇 |
1987年 | 102篇 |
1986年 | 102篇 |
1985年 | 122篇 |
1984年 | 94篇 |
1983年 | 61篇 |
1982年 | 81篇 |
1981年 | 83篇 |
1980年 | 42篇 |
1979年 | 40篇 |
1978年 | 30篇 |
1977年 | 20篇 |
1976年 | 18篇 |
1975年 | 7篇 |
排序方式: 共有10000条查询结果,搜索用时 93 毫秒
51.
52.
Breast cancer is the female malignant neoplasia with the highest incidence in the industrialized world. Despite many undeniable therapeutic successes obtained, breast cancer still remains, however, a major health issue. In the last few years, thanks to aromatase inhibitors, the hormone therapy for oestrogen-dependent breast cancer has evolved in terms of efficacy and tolerability; at the same time, it has enabled us to better define the role of oestrogens in the etiopathogenesis of this tumour. Weight increase and obesity have been identified as the most important risk and prognostic factors for breast cancer in postmenopausal women. Several hypotheses have been proposed to explain the association of obesity with postmenopausal breast cancer. A more recent hypothesis suggests that adipocytes and their autocrine (paracrine and endocrine actions) are at the centre of such an etiopathogenetic mechanism. A better understanding of the main mechanisms that link together menopause, body-weight increase and hormone-dependent breast cancer is paramount to enable the identification of key molecules involved in the development of breast carcinoma and suggest new therapeutic options. The present review will discuss important findings on the therapeutic aspects of adipose tissue and adipokines as a target for treatment of hormone-dependent breast cancer. 相似文献
53.
Objective: To study the diagnostic value of T2^*-weighted first-pass perfusion imaging in breast tumors. Methods: We analyzed the magnetic resonance imaging (MRI) information along with the pathological and immunohistochemistry results. Magnetic resonance imaging was performed in 28 patients with breast tumor. The time to signal intensity curves were generated according to the T2^*-weighted first-pass perfusion imaging. The curve's maximal signal intensity drop rate and maximal signal intensity decrease time were analyzed and compared with the pathological diagnoses after surgery. Results: Malignant breast lesions showed higher maximal signal intensity drop rate (44.69% ± 17.07 vs. 17.22% ±7.49, P 〈 0.001) than benign lesions, but there was no significant difference of maximal signal decrease time between those two lesions (23.94 s ± 4.92 vs. 20.02 s ± 6.83, P 〉 0.05). Conclusion: The T2^*-weighted first-pass perfusion imaging has enough sensitivity and specificity in breast tumor diagnosis. 相似文献
54.
原位杂交法检测BP1基因在乳腺癌组织中表达 总被引:3,自引:0,他引:3
目的探讨BP1同源盒基因在乳腺癌中的表达及其与临床病理指标的关系。方法收集165例乳腺癌临床和病理资料,采用原位杂交法检测BP1的表达,同时用二步法进行ER、p53、PCNA、bcl2、cerbB2免疫组化染色。结果BP1基因表达率为67.88%,免疫组化:ER70.30%、p5349.09%、PCNA74.55%、bcl253.33%、cerbB275.52%。BP1与bcl2具有相关性(P<0.01),且均与ER相关(P<0.05),与p53呈负相关(P<0.05)。BP1与PCNA、cerbB2、患者年龄、组织学类型、淋巴结转移等无相关性。结论BP1可能通过某种非依赖p53基因调控机制,与bcl2、ER协同抑制肿瘤细胞的凋亡而参与乳腺癌的发生。 相似文献
55.
J.P. Brouillet B. Hanslick T. Maudelonde M.T. Pivat J. Grenier F. Blanc H. Rochefort 《Clinical biochemistry》1991,24(6):491-496
Using a sandwich enzyme-linked immunoassay, plasma total cathepsin D concentration was assayed in 40 breast cancer patients and 84 patients with various liver diseases and compared to that of 52 normal subjects. There were no significant variations found in breast cancer patients related to tumor size, node invasiveness or metastases. In normal women, cathepsin D levels were slightly but not significantly increased in the luteal phase and in pregnancy. By contrast, plasma cathepsin D concentration was significantly increased in 70-75% of patients with liver disease (cirrhosis, hepatocarcinoma, hepatitis), but not in those with liver steatosis. Cathepsin D was independent of most of the plasma hepatic function tests and was correlated with alpha-fetoprotein in cirrhosis and with alpha-fucosidase in primary hepatocellular carcinoma. We conclude that plasma cathepsin D is not a useful marker in breast cancer. However, since the cellular level of this protease is associated with risk of metastasis in breast cancer, clinical follow-up will be required to test whether high cathepsin D plasma concentration has any prognostic value in liver cirrhosis and primary hepatocarcinoma. 相似文献
56.
Yanli Song Dong Wang 《中国肿瘤临床(英文版)》2007,4(2):142-144
OBJECTIVE To investigate the effect of neoadjuvant chemotherapy in treatment of Stage Ⅱ breast cancer.
METHODS The data from 113 patients with breast cancer of the same pathologic type in Stage Ⅱ,during the period of 1995 to 2001,were analyzed retrospectively.Among the patients,47 were treated with neoadjuvant chemotherapy,and 66 received no adjuvant therapy before surgery(control group).After the patients of the neoadjuvant chemotherapy group had received 2 courses of chemotherapy with the CMF regimen,the surgical procedure was conducted.
RESULTS Complete remission(CR)was attained in 9 of the 47 cases receiving neoadjuvant chemotherapy and partial remission(PR)was reached for 22 cases.The rate of breast-conserving surgery was enhanced from 22.73%to 46.81%(P〈0.05)in the neoadjuvant treatment group.
There was no difference in the 5-year overall survival(OS)and disease-free survival(DFS)rate between the two groups(P〉0.05),but the 5-year OS and DFS of the cases with clinical tumor remission was higher compared to the control group(P〈0.05).
CONCLUSION Neoadjuvant chemotherapy can enhance the rate of breast conservation for Stage Ⅱ breast cancer and may improve the prognosis of the cases with clinical remission. 相似文献
57.
目的:探讨靶重建放大扫描技术对肺孤立性结节病变的诊断价值。方法:对63例患者先行常规CT平扫,选定结节处为兴趣区,行薄层靶重建放大扫描,层厚、层距为2mm,FOV为160。结果:42例恶性病变中有37例表现为深分叶,占88.1%;21例良性病变中有15例表现为浅分叶,占71.4%。恶性结节中15例内部出现条状低密度支气管征;7例出现血管集中征;8例出现空泡征;病变内部出现液化坏死13例,其中恶性病变ll例。22例出现钙化,包括12例良性病变和10例恶性病变。2例错构瘤内均见小面积脂肪性低密度影。结论:靶重建放大扫描比普通CT扫描可提供更多的信息,对良恶性病变的鉴别诊断有一定价值。恶性病变大多数为深分叶,良性病变大多数为浅分叶或无分叶。 相似文献
58.
目的 检测乳腺癌骨髓微转移 ,探讨其与乳腺癌临床病理学因素的关系。方法 采用RT -PCR法 (一步法 )检测骨髓中CK19mRNA表达。结果 10 2例乳腺癌患者骨髓CK19mR NA表达阳性率 5 6.9%。骨髓CK19mRNA表达率随乳腺癌肿块增大而增高 ;随临床分期增加而增高 ;随组织学分级增加而增高。但与腋淋巴结转移与否无关 ,亦与乳腺癌患者年龄、月经状况及病理类型无关。结论 乳腺癌骨髓微转移与某些临床病理学因素有关。癌细胞播散无固定模式 ,早期乳腺癌亦可发生远处转移。骨髓微转移应作为常规检测方法 ,以更早、更准确地预测全身转移情况 ,进行个体化治疗。 相似文献
59.
目的探讨增强产妇健康信念对产妇分娩方式及产后康复的影响,提高产妇康复质量及产科工作质量。方法将300例产妇随机分为观察组和对照组,对观察组产妇进行分娩相关知识强化培训,增强产妇自然分娩及自我护理信念.对照组只进行一般入院宣教,比较两组剖宫产率、纯母乳喂养、产后24小时自护率等指标。结果观察组产妇剖宫产率明显低于对照组,而纯母乳喂齐、产后24小时自护率等指标均高于对照组。结论增强产妇健康信念,能帮助其自然分娩,降低剖宫产率,提高产妇康复质量。 相似文献
60.
目的:比较乳腺可扪及囊肿穿刺抽液后服用三苯氧胺和单纯穿刺抽液两种治疗方法的疗效.方法:将临床可扪及乳腺囊肿根据乳腺B超检查结果入组68例,随机分为穿刺抽液治疗组32例和穿刺抽液后服三苯氧胺治疗组36例,两组患者穿刺抽液后中位随访13个月观察疗效.结果:68例可扪及乳腺单纯囊肿,平均囊肿大小23mm,36例穿刺服三苯氧胺组复发率13.89%(5/36),32例穿刺抽液组复发率37.50%(12/32),两组相比较(P<0.05)有显著性差异.乳腺囊肿病史>1年的患者,穿刺服三苯氧胺组和穿刺组复发率分别是36.36%(4/11)和77.78%(7/9),两组相比较(P<0.05)差异有显著性.对单个囊肿,多发囊肿,囊肿病史<1年患者,两种治疗方法不影响复发率(P>0.05).结论:临床可扪及乳腺单纯囊肿可根据B超检查筛选适合穿刺患者,穿刺抽液加服三苯氧胺治疗可减少复发,囊肿病史>1年者复发率较高. 相似文献